05:48 PM EDT, 08/26/2024 (MT Newswires) -- Hans Van Houte, Chief Financial Officer, on August 26, 2024, sold 20,000 shares in Nurix Therapeutics ( NRIX ) for $504,370. Following the Form 4 filing with the SEC, Van Houte has control over a total of 31,002 shares of the company, with 31,002 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1549595/000154959524000112/xslF345X05/wk-form4_1724708492.xml

Price: 25.60, Change: -0.09, Percent Change: -0.35